These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 318891)
1. Relevance of fatty acids in multiple sclerosis. Mertin J; Meade CJ Br Med Bull; 1977 Jan; 33(1):67-71. PubMed ID: 318891 [No Abstract] [Full Text] [Related]
2. Essential fatty acids and related molecular and cellular mechanisms in multiple sclerosis: new looks at old concepts. Mayer M Folia Biol (Praha); 1999; 45(4):133-41. PubMed ID: 10732726 [TBL] [Abstract][Full Text] [Related]
15. Antigen-specific immunosuppression: oral tolerance for the treatment of autoimmune disease. Hafler DA; Weiner HL Chem Immunol; 1995; 60():126-49. PubMed ID: 7857525 [No Abstract] [Full Text] [Related]
16. Approach to the patient with a fatty acid oxidation disorder. Saudubray JM; Mitchell G; Bonnefont JP; Schwartz G; Nuttin C; Munnich A; Brivet M; Vassault A; Demaugre F; Rabier D Prog Clin Biol Res; 1992; 375():271-88. PubMed ID: 1438373 [No Abstract] [Full Text] [Related]
17. Polyunsaturated fatty acids and their potential therapeutic role in multiple sclerosis. Mehta LR; Dworkin RH; Schwid SR Nat Clin Pract Neurol; 2009 Feb; 5(2):82-92. PubMed ID: 19194388 [TBL] [Abstract][Full Text] [Related]
18. Fatty acid pattern of lymphocytes in multiple sclerosis patients after high doses of maxEPA. Rosnowska M; Cendrowski W Mater Med Pol; 1987; 19(4):239-41. PubMed ID: 3454832 [No Abstract] [Full Text] [Related]
19. Immunomodulatory and therapeutic effects of Hot-nature diet and co-supplemented hemp seed, evening primrose oils intervention in multiple sclerosis patients. Rezapour-Firouzi S; Arefhosseini SR; Mehdi F; Mehrangiz EM; Baradaran B; Sadeghihokmabad E; Mostafaei S; Fazljou SM; Torbati MA; Sanaie S; Zamani F Complement Ther Med; 2013 Oct; 21(5):473-80. PubMed ID: 24050582 [TBL] [Abstract][Full Text] [Related]